Skip to main content
NeuroThera Labs Inc. logo

NeuroThera Labs Inc. — Investor Relations & Filings

Ticker · NTLX ISIN · CA64136J1012 LEI · 529900GPL3C0DVADMS32 TSXV Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2024-10-02 Regulatory Filings
Country CA Canada
Listing TSXV NTLX

About NeuroThera Labs Inc.

https://www.neurothera.com/

NeuroThera Labs Inc. is a clinical-stage company specializing in the development of therapeutics and advanced technologies for central nervous system (CNS) disorders and brain health. The company operates through two primary development streams. First, it is a leader in photobiomodulation (PBM) technology, developing drug-free, non-invasive devices for neurotherapy, targeting conditions such as Major Depressive Disorder (MDD), Alzheimer’s Disease, and Traumatic Brain Injury (TBI). Second, NeuroThera maintains a pharmaceutical pipeline focused on novel drug candidates, including programs based on THC and proprietary opioid/non-opioid compounds designed to enhance pain relief and treat CNS disorders. This dual approach leverages both advanced medical devices and clinical-stage drug candidates to address prevalent neurological conditions.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CFO of Miza III Ventures Inc. It certifies the review and fair presentation of the interim financial report for the period ended July 31, 2024. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It explicitly states it is a certification and not the interim report itself. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR). The document length is under 5,000 characters and is a certification, not the report itself.
2024-10-02 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management Discussion and Analysis' (MD&A) for the three and six months ended July 31, 2024. It contains detailed financial data, analysis of results of operations, liquidity and capital resources, related party transactions, risks and uncertainties, and management's responsibility for financial information. The presence of quarterly period data and substantive financial analysis indicates this is an interim or quarterly report. The document is over 11,000 characters, so it is not a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q2 2025
2024-10-02 English
Interim financial statements/report – English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CEO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended July 31, 2024. It explicitly states it is a certification related to interim filings, not the filings themselves. The document is short (2985 characters) and primarily an officer certification letter. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS), not as the interim report (IR) itself, since it does not contain substantive financial data or analysis but only certifies the filings.
2024-10-02 English
Notice of meeting - English.pdf
AGM Information Classification · 95% confidence The document is a Notice of Annual General and Special Meeting for Miza III Ventures Inc. It outlines the agenda for the meeting, including receiving and considering the audited annual consolidated financial statements, appointing auditors, fixing the number of directors, electing directors, and approving stock option and equity incentive plans. It also mentions accompanying materials such as a management information circular and proxy forms. The document is a notice inviting shareholders to the meeting rather than the actual meeting materials or reports themselves. The document length is 3372 characters, which is relatively short and consistent with a meeting notice. Therefore, this document fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting, or more specifically, notices related to the AGM.
2024-08-21 English
Form of proxy - English.pdf
AGM Information Classification · 95% confidence The document is a Form of Proxy for the Annual General & Special Meeting of Miza III Ventures Inc. It includes instructions for appointing a proxyholder, voting methods, and voting recommendations on various resolutions such as election of directors, appointment of auditor, and approval of stock option and equity incentive plans. It also contains a section for shareholders to request financial statements. The document is clearly a solicitation for votes and proxy appointment related to the AGM, not the AGM materials or the actual meeting minutes or reports. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related proxy materials. The document length and content confirm it is not a brief announcement or a report publication notice, but a proxy form for the AGM.
2024-08-21 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is a short form requesting recipients to indicate whether they want to receive Interim Financial Statements or Annual Financial Statements by mail or email. It does not contain any actual financial data, analysis, or report content. It is essentially a notification or request form related to distribution of financial reports, not the reports themselves. The document length is only 1124 characters, which is very short and consistent with a notice or request rather than a full report. Therefore, it fits best as a Regulatory Filing (RNS) because it is a miscellaneous regulatory communication that does not fit other categories.
2024-08-21 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.